Cleared Traditional

CLAROX plus (Model: VX-100) (K221417) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K221417 · Vsi Co., Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2022
Decision
120d
Days
Class 2
Risk

K221417 is an FDA 510(k) clearance for the CLAROX plus (Model: VX-100). Classified as System, X-ray, Mobile (product code IZL), Class II - Special Controls.

Submitted by Vsi Co., Ltd. (Cheongju-Si, KR). The FDA issued a Cleared decision on September 13, 2022 after a review of 120 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1720 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Vsi Co., Ltd. devices

Submission Details

510(k) Number K221417 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 16, 2022
Decision Date September 13, 2022
Days to Decision 120 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d slower than avg
Panel avg: 107d · This submission: 120d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IZL System, X-ray, Mobile
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1720
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Lighten Bridge, LLC
Edward Park

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - IZL System, X-ray, Mobile

All 95
Devices cleared under the same product code (IZL) and FDA review panel - the closest regulatory comparables to K221417.
Combined High Frequency X-ray Source
K222258 · Suzhou Powersite Electric Co., Ltd. · Nov 2022
uDR 380i Pro
K222339 · Shanghai United Imaging Healthcare Co., Ltd. · Sep 2022
GM85
K222353 · Samsung Electronics Co., Ltd. · Sep 2022
PHOENIX/AeroDR TX m01 and PHOENIX/mKDR Xpress.
K221803 · Sedecal., Sa. · Jul 2022
MINE ALNU (Model: Mine 2.1)
K213405 · Hdt Co., Ltd. · Jul 2022
iQFlex M Mobile X-ray System, iQFlex MD Mobile X-ray System
K221081 · First Source, Inc. · Jun 2022